Assuntos
Humanos , Feminino , Adolescente , Baço/diagnóstico por imagem , Tuberculose Esplênica/diagnóstico , Tuberculose Esplênica/tratamento farmacológico , Esclerite/diagnóstico , Hepatite Autoimune/tratamento farmacológico , Enterite/diagnóstico , Febre , Mycobacterium tuberculosis/isolamento & purificação , Esplenectomia , Hospedeiro Imunocomprometido , Diagnóstico DiferencialRESUMO
A 65-year-old woman underwent FDG PET/CT for presumed hepatosplenic malignancy suggested by an abdominal CT. The images revealed multiple foci of intense FDG activity in both the liver and the spleen. However, a splenic biopsy result revealed no malignant cells, and either tuberculosis or sarcoidosis was proposed. Following an incomplete antituberculosis therapy, a repeat FDG PET/CT showed resolution of the abnormal activity in the liver and the spleen.
Assuntos
Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Tuberculose Hepática/diagnóstico por imagem , Tuberculose Esplênica/diagnóstico por imagem , Idoso , Feminino , Fluordesoxiglucose F18 , Humanos , Compostos Radiofarmacêuticos , Tuberculose Hepática/tratamento farmacológico , Tuberculose Esplênica/tratamento farmacológicoAssuntos
Adalimumab/efeitos adversos , Antirreumáticos/efeitos adversos , Síndrome Inflamatória da Reconstituição Imune/induzido quimicamente , Abscesso Hepático/etiologia , Tuberculose Hepática/etiologia , Tuberculose Miliar/etiologia , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adalimumab/uso terapêutico , Adulto , Antirreumáticos/uso terapêutico , Antituberculosos/uso terapêutico , Substituição de Medicamentos , Quimioterapia Combinada , Feminino , Humanos , Síndrome Inflamatória da Reconstituição Imune/complicações , Hospedeiro Imunocomprometido , Tuberculose Latente/complicações , Abscesso Hepático/diagnóstico por imagem , Abscesso Hepático/tratamento farmacológico , Mesalamina/uso terapêutico , Proctocolite/complicações , Proctocolite/tratamento farmacológico , Tuberculose Hepática/tratamento farmacológico , Tuberculose dos Linfonodos/complicações , Tuberculose dos Linfonodos/tratamento farmacológico , Tuberculose Miliar/diagnóstico , Tuberculose Miliar/tratamento farmacológico , Tuberculose Esplênica/diagnóstico por imagem , Tuberculose Esplênica/tratamento farmacológico , Tuberculose Esplênica/etiologiaRESUMO
For many years, tuberculosis (TB) has been endemic in Pakistan; many rare and unusual presentations have been reported. There is a myriad of non-specific symptoms which always requires a high index of clinical suspicion for TB. World Health Organization data suggest that Pakistan ranks as the fifth highest country burdened with TB and has the fourth highest prevalence of multi-drug resistant TB globally. With an annual incidence of 277 cases per 100,000, the importance of early diagnosis and treatment is self-evident. We present a case where a strong suspicion of isolated hepatosplenic TB in an immunocompetent patient justified a directed approach.
Assuntos
Tuberculose Hepática/diagnóstico , Tuberculose Esplênica/diagnóstico , Adulto , Antituberculosos/uso terapêutico , Humanos , Hospedeiro Imunocomprometido , Masculino , Mycobacterium tuberculosis/isolamento & purificação , Tomografia Computadorizada por Raios X , Tuberculose Hepática/tratamento farmacológico , Tuberculose Hepática/microbiologia , Tuberculose Esplênica/tratamento farmacológico , Tuberculose Esplênica/microbiologiaRESUMO
BACKGROUND: Isolated tuberculosis of the spleen has been described occasionally in literature, mostly in immunosuppressed individuals with various risk factors. Sequestration in the spleen makes such Mycobacterium tuberculosis infection difficult to diagnose. This report describes an extremely rare case of isolated splenic tuberculosis in an immunocompetent individual. CASE PRESENTATION: A 26 year old Kenyan male presented with pyrexia of unknown origin, with negative screening tests for bacterial, fungal and parasitic infections. Ziehl-Neelsen staining and GeneXpert tests were negative for M. tuberculosis. Diagnosis of isolated splenic tuberculosis was made on core biopsy of the spleen. The patient initially worsened upon treatment with antituberculous medication attributable to the 'Paradoxical Reaction' phenomenon, before making full recovery. CONCLUSIONS: This case highlights the need to continuously be on the lookout for tuberculosis especially in unusual presentations, including subsequent paradoxical reaction which may be encountered.
Assuntos
Antituberculosos/uso terapêutico , Febre/diagnóstico por imagem , Baço/diagnóstico por imagem , Tuberculose Esplênica/diagnóstico por imagem , Adulto , Biópsia por Agulha Fina , Febre/tratamento farmacológico , Febre/imunologia , Febre/microbiologia , Humanos , Imunocompetência , Masculino , Mycobacterium tuberculosis/efeitos dos fármacos , Mycobacterium tuberculosis/patogenicidade , Mycobacterium tuberculosis/fisiologia , Baço/microbiologia , Baço/patologia , Baço/cirurgia , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Tuberculose Esplênica/tratamento farmacológico , Tuberculose Esplênica/imunologia , Tuberculose Esplênica/microbiologiaRESUMO
No disponible
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Tuberculose Miliar/complicações , Tuberculose Miliar/tratamento farmacológico , Tuberculose Esplênica/complicações , Tuberculose Esplênica/tratamento farmacológico , Azatioprina/efeitos adversos , Azatioprina/uso terapêutico , Esplenectomia/métodos , Antituberculosos/uso terapêutico , Artéria Esplênica , Artéria Esplênica/lesões , Lacerações/induzido quimicamente , Lacerações/complicações , Lacerações/tratamento farmacológico , Laparotomia/métodos , Mycobacterium tuberculosis , Mycobacterium tuberculosis/isolamento & purificaçãoRESUMO
We report a case of a 61-year-old man who presented with a cough and abdominal discomfort. CT scan of the chest showed two lesions across both lungs, and an abdominal CT scan revealed multiple hypodense lesions in the spleen with cystic lesions on the splenic hilum. Upper gastrointestinal tract endoscopy found creamy yellowish discharge through a fistula between the stomach and splenic hilum. Under fluoroscopic guidance, forceps was inserted into the fistula tract, and forcep biopsy was done. The pathology was consistent with tuberculosis, and a nine-month anti-tuberculosis medication regimen was started. Imaging performed three months after finishing medication indicated improvement of splenic lesions, and the gastro-splenic tract was sealed off. This case is a very rare clinical example of secondary splenic tuberculosis with a gastro-splenic fistula formation in an immunocompetent patient.
Assuntos
Esplenopatias/diagnóstico , Tuberculose Esplênica/diagnóstico , Antituberculosos/uso terapêutico , Fluoroscopia , Fístula Gástrica/patologia , Gastroscopia , Humanos , Masculino , Pessoa de Meia-Idade , Baço/diagnóstico por imagem , Baço/patologia , Esplenopatias/diagnóstico por imagem , Esplenopatias/patologia , Tomografia Computadorizada por Raios X , Tuberculose Esplênica/tratamento farmacológico , Tuberculose Esplênica/microbiologia , UltrassonografiaRESUMO
Tuberculosis caused by Mycobacterium tuberculosis presents a major health challenge in endemic countries and spares no organ in the human body. This infection is a mimicker of various disease processes such as metastasis, lymphoproliferative diseases, and other granulomatous conditions such as sarcoidosis and fungal infections. The most challenging and important differential is metastasis, especially in the disseminated form of tuberculosis. We present a histopathologically proven case of isolated hepatosplenic tuberculosis that was provisionally diagnosed as lymphoma due to its unusual, restricted involvement of the liver and spleen.
Assuntos
Dor Abdominal/etiologia , Antituberculosos/administração & dosagem , Tomografia Computadorizada por Raios X , Tuberculose Hepática/diagnóstico , Tuberculose Esplênica/diagnóstico , Diagnóstico Diferencial , Etambutol/administração & dosagem , Feminino , Humanos , Isoniazida/administração & dosagem , Pessoa de Meia-Idade , Pirazinamida/administração & dosagem , Rifampina/administração & dosagem , Resultado do Tratamento , Tuberculose Hepática/complicações , Tuberculose Hepática/tratamento farmacológico , Tuberculose Esplênica/complicações , Tuberculose Esplênica/tratamento farmacológico , Redução de PesoRESUMO
Effective global tuberculosis control is hindered by the need for prolonged chemotherapy which leads to poor patient compliance. Therefore novel drug targets that shorten the duration of chemotherapy and reduce disease relapse rates are highly desirable. We have previously shown that HspX, an alpha-crystallin-like protein, is associated with growth suppression of Mycobacterium tuberculosis in mouse models. We determined to evaluate hspX as a novel target for controlling M. tuberculosis growth in combination with traditional antibiotic therapy in the Cornell mouse model. The hspX deletion mutant (ΔhspX) was used as a model of potential hspX inhibition. Normal BALB/c mice were infected with ΔhspX or the wild type (WT) strain. Three weeks after infection, the mice were treated with rifampicin, isoniazid and pyrazinamide for 14 weeks followed by 8 weeks of hydrocortisone. The effect of chemotherapy was measured by organ bacterial counts and the relapse rate. Antibiotic treatment of mice infected with ΔhspX resulted in faster visceral clearance; organs were disease free 8 weeks post-treatment for ΔhspX infection compared to 14 weeks for the WT strain. Disease relapse rate was significantly lower in ΔhspX infection (60.7%) compared to WT infection (92.6%). HspX may be a promising therapeutic target in combination with traditional antibiotic therapy to shorten the length of treatment and reduce disease relapse.
Assuntos
Antibacterianos/farmacologia , Proteínas de Bactérias/antagonistas & inibidores , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Esplênica/tratamento farmacológico , Animais , Anti-Inflamatórios/farmacologia , Antígenos de Bactérias/genética , Proteínas de Bactérias/genética , Células Cultivadas , Modelos Animais de Doenças , Quimioterapia Combinada , Feminino , Técnicas de Inativação de Genes , Hidrocortisona/análogos & derivados , Hidrocortisona/farmacologia , Imunossupressores/farmacologia , Camundongos Endogâmicos BALB C , Mutação/genética , Mycobacterium tuberculosis/genética , RecidivaAssuntos
Abscesso/complicações , Abscesso/diagnóstico por imagem , Ruptura Esplênica/diagnóstico por imagem , Ruptura Esplênica/etiologia , Tuberculose Esplênica/complicações , Tuberculose Esplênica/diagnóstico por imagem , Abscesso/cirurgia , Antituberculosos/uso terapêutico , Diagnóstico Diferencial , Drenagem/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Ruptura Espontânea , Baço/diagnóstico por imagem , Baço/cirurgia , Esplenectomia/métodos , Ruptura Esplênica/cirurgia , Tomografia Computadorizada por Raios X/métodos , Tuberculose Esplênica/tratamento farmacológicoRESUMO
The potential of (18)F-FDG PET/CT in the diagnosis and treatment response monitoring of fever of unknown origin (resulting from hepatosplenic tuberculosis) is demonstrated in this report. The patient was a 32-y-old woman who had presented to us with a history of pyrexia of unknown origin for the past 2 mo. On investigation, she was found to have hepatic and splenic granulomas, with whole-body (18)F-FDG PET demonstrating abnormal (18)F-FDG-avid foci in the liver and spleen. Ultrasonography-guided liver biopsy was suggestive of granulomatous hepatitis. The patient was clinically nonresponsive to first-line antitubercular drugs, and second-line antitubercular medications were added subsequently in view of clinical nonresponse. The patient responded well to the treatment. The repeated CT scan at 11 mo demonstrated persistence of the splenic granulomas; however, follow-up (18)F-FDG PET/CT at the same time showed resolution of (18)F-FDG-concentrating active disease foci with suggestion of complete metabolic response, commensurate with the patient's clinical improvement.
Assuntos
Febre/diagnóstico , Fluordesoxiglucose F18 , Imagem Multimodal/métodos , Tomografia por Emissão de Pósitrons/métodos , Tomografia Computadorizada por Raios X/métodos , Tuberculose/diagnóstico , Adulto , Antituberculosos/uso terapêutico , Diagnóstico Diferencial , Feminino , Febre/complicações , Febre/tratamento farmacológico , Seguimentos , Humanos , Fígado/diagnóstico por imagem , Compostos Radiofarmacêuticos , Baço/diagnóstico por imagem , Resultado do Tratamento , Tuberculose/complicações , Tuberculose/tratamento farmacológico , Tuberculose Hepática/complicações , Tuberculose Hepática/diagnóstico , Tuberculose Hepática/tratamento farmacológico , Tuberculose Esplênica/complicações , Tuberculose Esplênica/diagnóstico , Tuberculose Esplênica/tratamento farmacológico , Imagem Corporal Total/métodosRESUMO
Pulmonary tuberculosis is very devastating in developing countries and its thrombogenic potential is a disturbing new entity. We report an 18-year-old woman who presented with a first episode of deep vein thrombosis. Pulmonary, hepatic and splenic tuberculosis was diagnosed while looking for secondary causes. The patient was treated with rifampicin, isoniazid, pyrazinamide and ethambutol along with low-molecular-weight heparin and antivitamin K. Tuberculosis has several mechanisms that induce a hypercoagulable state and can lead to thromboembolic complications.
Assuntos
Tuberculose Hepática/complicações , Tuberculose Pulmonar/complicações , Tuberculose Esplênica/complicações , Trombose Venosa/complicações , Adolescente , Anticoagulantes/uso terapêutico , Antituberculosos/uso terapêutico , Feminino , Humanos , Trombofilia/sangue , Trombofilia/tratamento farmacológico , Tuberculose Hepática/sangue , Tuberculose Hepática/tratamento farmacológico , Tuberculose Pulmonar/sangue , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Esplênica/sangue , Tuberculose Esplênica/tratamento farmacológico , Trombose Venosa/sangue , Trombose Venosa/tratamento farmacológicoRESUMO
Fever of undetermined origin always poses a challenging problem to the physician. Tuberculosis is an important health problem in developing countries. It is mostly seen in immune-compromised patients. And it is one of the common causes of fever of unknown origin. I am reporting a case of a splenic tuberculosis in 48 years old male who is not known of any immune deficiency state, he was presented with 3 weeks history of fever and found to have severe neutropenia and with negative work up for all hematological, rheumatological and malignant causes. A computerized tomography scan of the abdomen confirmed splenic enlargement with multiples hypo dense lesions consist with either splenic infection or splenic lymphoma so exploratory splenectomy was performed. Histological examination revealed granulomatouse inflammation with numerous acid fast bacilli consist with tuberculosis. He was started on four anti-tuberculouse drugs. in less than one week his fever subside with normalization of his neutrophilic count.